Is Hester Biosciences stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hester Biosciences pays dividends. Last time was Saturday 28th of September 2024 where the investors holding the stock on Thursday 22nd of August 2024 were paid INR6 per share. Over the last 15 times between 2015 and 2024, Hester Biosciences has paid INR74.1 with an average of INR4.94 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hester Biosciences 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 678.95, you would have made a profit of INR747.90 per share or 44.55%
Yes, the average daily trading liquidity for Hester Biosciences is INR23 823 thousand. You should therefore be able to get in and out of your positions relatively fast.
Hester Biosciences has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.11, the company's ability to pay off the debt is normal. Hester Biosciences has a good net profit margin of 6.20% and should have high tolerances against inflation.
We have calculated the inflation risk for Hester Biosciences to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.